Key Takeaways
- • Hedge fund bullish bets on U.S. healthcare stocks reached near five-year highs as of the week ending July 27, 2026, according to Goldman Sachs analysis, signaling intensified conviction in sector recovery.
- • Approximately $283 billion of the roughly $1 trillion in assets managed by equity hedge funds is deployed in healthcare-focused strategies, representing a substantial concentration of alternative capital in the sector.
- • Healthcare sector performance has shown marked improvement in 2025 with 12.5% returns year-to-date, following three years of underperformance versus the S&P 500 (0.3% in 2023, 0.9% in 2024), creating a potential inflection point attracting hedge fund capital.
- • Hedge funds are actively increasing long positioning in healthcare equities, reversing earlier patterns of defensive positioning and reflecting growing institutional confidence in the sector's near-term momentum.
Summary
Hedge funds have significantly amplified their bullish positioning in U.S. healthcare stocks, with long bets reaching levels not seen in approximately five years, according to Goldman Sachs research released on July 27, 2026. This uptick in healthcare exposure reflects a broader reassessment of the sector's investment merit among sophisticated allocators managing alternative strategies.
The scale of institutional capital deployed in healthcare strategies underscores the sector's importance to the hedge fund community. Goldman Sachs data indicates that of the approximately $1 trillion in assets managed by equity-focused hedge funds globally, roughly $283 billion is concentrated within healthcare-specializing funds. This represents meaningful exposure to sector-specific dynamics and regulatory developments affecting pharmaceutical, medical device, and healthcare services companies.
The timing of increased hedge fund conviction in healthcare stocks aligns with a significant performance inflection. After three consecutive years of underperformance relative to the S&P 500—posting returns of just 0.3% in 2023 and 0.9% in 2024—the healthcare sector delivered 12.5% returns through 2025, suggesting a potential sector rotation is underway. Year-to-date performance through mid-2026 further supports this thesis, indicating that hedge funds may be positioning ahead of continued sector strength.
This elevated positioning in healthcare equities represents a tactical shift in hedge fund allocation patterns, with managers apparently rotating from defensive postures into more constructive healthcare exposure. The near five-year high in bullish bets signals that institutional investors view current valuations and fundamental catalysts as compelling opportunities within the healthcare complex, despite historical underperformance that lasted through much of the prior three-year period.
The scale of institutional capital deployed in healthcare strategies underscores the sector's importance to the hedge fund community. Goldman Sachs data indicates that of the approximately $1 trillion in assets managed by equity-focused hedge funds globally, roughly $283 billion is concentrated within healthcare-specializing funds. This represents meaningful exposure to sector-specific dynamics and regulatory developments affecting pharmaceutical, medical device, and healthcare services companies.
The timing of increased hedge fund conviction in healthcare stocks aligns with a significant performance inflection. After three consecutive years of underperformance relative to the S&P 500—posting returns of just 0.3% in 2023 and 0.9% in 2024—the healthcare sector delivered 12.5% returns through 2025, suggesting a potential sector rotation is underway. Year-to-date performance through mid-2026 further supports this thesis, indicating that hedge funds may be positioning ahead of continued sector strength.
This elevated positioning in healthcare equities represents a tactical shift in hedge fund allocation patterns, with managers apparently rotating from defensive postures into more constructive healthcare exposure. The near five-year high in bullish bets signals that institutional investors view current valuations and fundamental catalysts as compelling opportunities within the healthcare complex, despite historical underperformance that lasted through much of the prior three-year period.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.